AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Future of Psychedelics
At JAS, as Matthias mentioned, we don't invest in traditional therapeutic companies. We do have both a health care and a tech driven biology bucket vertical. For those companies looking for a mix, both of folks who are deep in the science understand the policy,. As more of a generalist fund, we want to see a team that understands product market.